Literature DB >> 12860392

The Raf/MEK inhibitor PD98059 enhances ERK1/2 phosphorylation mediated by peroxynitrite via enforced mitochondrial formation of reactive oxygen species.

Liana Cerioni1, Letizia Palomba, Orazio Cantoni.   

Abstract

Exposure of PC12 cells to 100 microM peroxynitrite promotes phosphorylation of extracellular signal-regulated kinases 1 and 2 (ERK1/2) sensitive to PD98059 or U0126. At higher concentrations, however, ERK1/2 phosphorylation was prevented by U0126 and increased by PD98059 via a U0126-sensitive mechanism. PD98059, unlike U0126, enhanced the peroxynitrite-dependent formation of reactive oxygen species (ROS). These results, along with others obtained using respiratory chain inhibitors and respiration-deficient cells, lead to the conclusion that PD98059, while effectively inhibiting the peroxynitrite-induced Raf/MEK signaling leading to ERK1/2 phosphorylation, promotes an enforced mitochondrial formation of ROS inducing ERK1/2 phosphorylation via a Raf-1-independent/MEK-dependent mechanism.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12860392     DOI: 10.1016/s0014-5793(03)00675-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Tilapia hepcidin 2-3 peptide modulates lipopolysaccharide-induced cytokines and inhibits tumor necrosis factor-alpha through cyclooxygenase-2 and phosphodiesterase 4D.

Authors:  Venugopal Rajanbabu; Chieh-Yu Pan; Shang-Chun Lee; Wei-Ju Lin; Ching-Chun Lin; Chung-Leung Li; Jyh-Yih Chen
Journal:  J Biol Chem       Date:  2010-07-30       Impact factor: 5.157

Review 2.  Nitric oxide and peroxynitrite in health and disease.

Authors:  Pál Pacher; Joseph S Beckman; Lucas Liaudet
Journal:  Physiol Rev       Date:  2007-01       Impact factor: 37.312

Review 3.  Current Development Status of MEK Inhibitors.

Authors:  Ying Cheng; Hongqi Tian
Journal:  Molecules       Date:  2017-09-26       Impact factor: 4.411

Review 4.  MEK inhibitors for the treatment of NRAS mutant melanoma.

Authors:  Saro Sarkisian; Diwakar Davar
Journal:  Drug Des Devel Ther       Date:  2018-08-20       Impact factor: 4.162

Review 5.  ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer.

Authors:  Reiko Sugiura; Ryosuke Satoh; Teruaki Takasaki
Journal:  Cells       Date:  2021-09-22       Impact factor: 6.600

6.  Hyperglycemia aggravates ischemic brain damage via ERK1/2 activated cell autophagy and mitochondrial fission.

Authors:  Ping Liu; Xiao Yang; Jianguo Niu; Changchun Hei
Journal:  Front Endocrinol (Lausanne)       Date:  2022-08-05       Impact factor: 6.055

7.  S100A12 suppresses pro-inflammatory, but not pro-thrombotic functions of serum amyloid A.

Authors:  Yuen Ming Chung; Jesse Goyette; Nicodemus Tedla; Kenneth Hsu; Carolyn L Geczy
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

8.  Intermittent hypoxia-induced protein phosphatase 2A activation reduces PC12 cell proliferation and differentiation.

Authors:  Tsung-I Chen; Hung-Wen Chiu; Yi-Chung Pan; Shih-Ting Hsu; Jian-Hong Lin; Kun-Ta Yang
Journal:  J Biomed Sci       Date:  2014-05-16       Impact factor: 8.410

9.  Antidepressant indatraline induces autophagy and inhibits restenosis via suppression of mTOR/S6 kinase signaling pathway.

Authors:  Yoon Sun Cho; Chih-Na Yen; Joong Sup Shim; Dong Hoon Kang; Sang Won Kang; Jun O Liu; Ho Jeong Kwon
Journal:  Sci Rep       Date:  2016-10-03       Impact factor: 4.379

10.  Antidepressant drug sertraline modulates AMPK-MTOR signaling-mediated autophagy via targeting mitochondrial VDAC1 protein.

Authors:  Hui-Yun Hwang; Joong Sup Shim; Dasol Kim; Ho Jeong Kwon
Journal:  Autophagy       Date:  2020-11-09       Impact factor: 16.016

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.